NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
17/10/2023
Voltar para busca
Dado oficial do USPTO
CIGNA PATHWELL BONE & JOINT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CIGNA PATHWELL BONE & JOINT
ST13
US500000097414087Classe
35, 36, 44
Pedido
97414087
Registro
7197678
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
17/10/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 36, 44
Data de depósito
17/05/2022
Data de registro
17/10/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/10/2023
Última transação
17/10/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
28/09/2022
Primeiro uso no comércio
25/10/2022
Código do desenho
4
Tipo de titular
03
Localização do titular
Wilmington, DE, US
Examinador
AREY, BRANDON LEON
Unidade examinadora
N90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Cigna Intellectual Property, Inc.
Representantes
Cigna Intellectual Property, Inc.
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Cost management for the healthcare benefit and prescription drug benefit plans of individuals with musculoskeletal conditions; business servicespharmaceutical cost management services and drug utilization review services for the prescription drug and medical formulary plans of others with musculoskeletal conditions; consulting services regarding healthcare costs management and retail pharmacy services for those with musculoskeletal conditions; Drug utilization review services and drug and medical formulary cost management services for those with musculoskeletal conditions; pharmaceutical and medical cost management services and drug utilization review services for those musculoskeletal conditions; in-network provider advisory services and consultancy servicesstrategic business analysis and business advice in the field of medical insurance regarding pharmacy benefit managementmedical benefit management; business data analysis regarding health care benefit plan pharmaceutical end-user behaviorhealth care benefit plan healthcare use behavior in the field of musculoskeletal conditions; market study and analysis of healthcarehealthcare benefitspharmacy benefits effecting health behavior change and choice at the patient level for musculoskeletal conditions; providing business intelligence services in the field of pharmacy benefit management; administration of employee benefit plans concerning pharmacy benefit plans for musculoskeletal patients; cost management for pharmacy health care benefit servicestrackingmonitoringassessing and analyzing information and statistics regarding patient prescription drug use and healthcare habitsproviding a predictive model to determine musculoskeletal patients' future prescription drug and healthcare habits to identify potential cost savings for those with musculoskeletal conditions
Classe 36
Pharmacy benefit management services; pharmacy benefit management consulting services for those with musculoskeletal conditions; medical benefit management services concerning insurance for those with musculoskeletal conditions; advisory services and consultancy regarding medical insurance healthcare benefitsin-network coveragepharmacy benefits; provision of information and analysis in the fields of healthcare insurance plan benefits and pharmacy benefits for those with musculoskeletal conditions; prescription health care benefit coverage plans servicesproviding insurance underwriting and claims administration of prescription drug plans for qualified beneficiaries with musculoskeletal conditions; administration of pharmacy benefit plans concerning insurance; pharmacy benefit management services concerning insurancetrackingmonitoringassessing and analyzing information and statistics regarding patient prescription drug use and healthcare habitsproviding a predictive model to determine musculoskeletal patients' future prescription drug and healthcare habitsall to identify clinical benefits for those with musculoskeletal conditions; prescription drug healthcare benefit plan servicesproviding information to patients regarding in-network services in the field of complex musculoskeletal case management programs
Classe 44
Advisory services and consultancy regarding musculoskeletal healthcare; healthcare serviceswellness and disease management programs for musculoskeletal patients; health care servicesmusculoskeletal disease management programs and complex musculoskeletal case management services in the nature of providing health consultation services to patients regarding medication compliance and providing healthcare and medical information regarding health and safety issues; providing medical information and analysis in the fields of musculoskeletal healthcarepharmaceuticals; providing information in the field of musculoskeletal healthcare to pharmacy benefit management clientsconsultants and brokers
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
17/10/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/09/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/09/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/09/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/09/2023
IUAF
USE AMENDMENT FILED
28/08/2023
EISU
TEAS STATEMENT OF USE RECEIVED
28/08/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
28/02/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/01/2023
PUBO
PUBLISHED FOR OPPOSITION
03/01/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/11/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/11/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/11/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/07/2022
GNRT
NON-FINAL ACTION E-MAILED
05/07/2022
CNRT
NON-FINAL ACTION WRITTEN
05/07/2022
DOCK
ASSIGNED TO EXAMINER
23/06/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/05/2022
NWAP
NEW APPLICATION ENTERED
20/05/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CIGNA PATHWELL BONE & JOINT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.